Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Michailidis

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2026
Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance MutationsShreya M Ravichandran, Alexa A Snyder, Katelyn H Kim, et al.
Plos One|January 21, 2011
K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanismAtsuko Hachiya, Eiichi N Kodama, Matthew M Schuckmann, et al.
International Journal of Current Chemistry|April 17, 2012
Hepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spotsEleftherios Michailidis, Kamlendra Singh, Karen A Kirby, et al.
Viruses|April 28, 2023
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C VirusDandan Liu, Tanya P Ndongwe, Juan Ji, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant StrainsMaria E Cilento, Aaron B Reeve, Eleftherios Michailidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Scientific Reports|June 3, 2015
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusVyas Ramanan, Amir Shlomai, David B T Cox, et al.
Plos Pathogens|January 26, 2013
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymesJohn E Tavis, Xiaohong Cheng, Yuan Hu, et al.
Scientific Reports|December 2, 2017
A robust cell culture system supporting the complete life cycle of hepatitis B virusEleftherios Michailidis, Jonathan Pabon, Kuanhui Xiang, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
<i>Myrtus communis</i> L. Essential Oil Exhibits Antiviral Activity against CoronavirusesDar-Yin Li, Matthew G Donadu, Taylor Shue, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|June 12, 2026
Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance MutationsShreya M Ravichandran, Alexa A Snyder, Katelyn H Kim, et al.
Plos One|January 21, 2011
K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanismAtsuko Hachiya, Eiichi N Kodama, Matthew M Schuckmann, et al.
International Journal of Current Chemistry|April 17, 2012
Hepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spotsEleftherios Michailidis, Kamlendra Singh, Karen A Kirby, et al.
Viruses|April 28, 2023
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C VirusDandan Liu, Tanya P Ndongwe, Juan Ji, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant StrainsMaria E Cilento, Aaron B Reeve, Eleftherios Michailidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Scientific Reports|June 3, 2015
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virusVyas Ramanan, Amir Shlomai, David B T Cox, et al.
Plos Pathogens|January 26, 2013
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymesJohn E Tavis, Xiaohong Cheng, Yuan Hu, et al.
Scientific Reports|December 2, 2017
A robust cell culture system supporting the complete life cycle of hepatitis B virusEleftherios Michailidis, Jonathan Pabon, Kuanhui Xiang, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
<i>Myrtus communis</i> L. Essential Oil Exhibits Antiviral Activity against CoronavirusesDar-Yin Li, Matthew G Donadu, Taylor Shue, et al.
Pageof 8